Kritika Srinivasan Rajsri (Kritika S Rajsri, Kritika Srinivasan)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Cancers

Bioengineering (Basel, Switzerland)

Therapeutic advances in infectious disease

Biosensors

New York University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

New York University School of Medicine

United States

PHD :: Sackler Institute

New York University College of Dentistry

United States

MSC :: Biomaterials

Publications

Kritika Srinivasan Rajsri, Nainita Roy, Sohini Chakraborty
Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15 , 2866. Cancers 16 (5) (2024)
Kritika Srinivasan Rajsri, Nainita Roy, Sohini Chakraborty
Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15 , 2866. Cancers 16 (5) (2024)
Kritika Srinivasan Rajsri, Michael P McRae, Nicolaos J Christodoulides, Isaac P Dapkins, Glennon W Simmons, Hanover Matz, Helen Dooley, David Fenyo, John T McDevitt
Simultaneous Quantitative SARS-CoV-2 Antigen and Host Antibody Detection and Pre-Screening Strategy at the Point of Care. Bioengineering (Basel, Switzerland) 10 (6) (2023)
Kritika Srinivasan Rajsri, Nainita Roy, Sohini Chakraborty
Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 15 (10) (2023)
Kritika Srinivasan Rajsri, Michael P McRae, Nicolaos J Christodoulides, Isaac P Dapkins, Glennon W Simmons, Hanover Matz, Helen Dooley, David Fenyo, John T McDevitt
Simultaneous Quantitative SARS-CoV-2 Antigen and Host Antibody Detection and Pre-Screening Strategy at the Point of Care. Bioengineering (Basel, Switzerland) 10 (6) (2023)
Michael P McRae, Kritika Srinivasan Rajsri, Timothy M Alcorn, John T McDevitt
Smart Diagnostics: Combining Artificial Intelligence and In Vitro Diagnostics. Sensors (Basel, Switzerland) 22 (17) (2022)
Kritika Srinivasan Rajsri, Mana Rao
Poxvirus-driven human diseases and emerging therapeutics. Therapeutic advances in infectious disease 9 (2022)
Kritika Srinivasan Rajsri, Michael P McRae, Glennon W Simmons, Nicolaos J Christodoulides, Hanover Matz, Helen Dooley, Akiko Koide, Shohei Koide, John T McDevitt
A Rapid and Sensitive Microfluidics-Based Tool for Seroprevalence Immunity Assessment of COVID-19 and Vaccination-Induced Humoral Antibody Response at the Point of Care. Biosensors 12 (8) (2022)
Kritika Srinivasan Rajsri, Mana Rao
Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review. Therapeutic advances in infectious disease 8 (2021)
Michael P McRae, Glennon W Simmons, Nicolaos J Christodoulides, Zhibing Lu, Stella K Kang, David Fenyo, Timothy Alcorn, Isaac P Dapkins, Iman Sharif, Deniz Vurmaz, Sayli S Modak, Kritika Srinivasan Rajsri, Shruti Warhadpande, Ravi Shrivastav, John T McDevitt
Clinical Decision Support Tool and Rapid Point-of-Care Platform for Determining Disease Severity in Patients with COVID-19. medRxiv : the preprint server for health sciences (2020)

Kritika Srinivasan Rajsri.css-eqlu8i{font-size:small;padding-left:4px;} (Kritika S Rajsri, Kritika Srinivasan)

Publication Activity (10 Years)

Top Topics

Top Venues

Kritika Srinivasan Rajsri (Kritika S Rajsri, Kritika Srinivasan)